Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Biote Corp

BTMD:NMQ

Biote Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)5.10
  • Today's Change-0.02 / -0.39%
  • Shares traded102.31k
  • 1 Year change-4.32%
  • Beta0.9281
Data delayed at least 15 minutes, as of Oct 31 2024 20:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.

  • Revenue in USD (TTM)187.23m
  • Net income in USD6.87m
  • Incorporated2020
  • Employees194.00
  • Location
    Biote Corp1875 W. Walnut Hill Ln #100, Floor 5IRVING 75038United StatesUSA
  • Phone+1 (972) 486-9346
  • Fax+1 (916) 443-1908
  • Websitehttps://haymakeracquisition.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BTMD:NMQ since
announced
Transaction
value
FH Investments IncAnnounced17 Jan 202417 Jan 2024Announced10.63%9.00m
Data delayed at least 15 minutes, as of Oct 31 2024 20:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Lee Enterprises Inc616.82m-17.74m110.81m2.83k--27.938.180.1797-3.01-3.01104.720.64090.8812.629.46217,801.90-2.201.04-2.661.2397.0596.12-2.501.120.86861.180.98590.00-11.504.91-161.13---3.25--
Chegg Inc683.34m-626.92m165.87m1.90k--0.4525--0.2427-6.12-6.125.833.540.4433--32.83359,084.60-40.672.58-51.082.7768.0370.64-91.748.07----0.62180.00-6.6017.41-93.18--21.61--
Goodheart-Willcox Company Inc-100.00bn-100.00bn250.91m56.00--6.93----------61.89----------------------------0.00--21.66--78.03------
biote Corp187.23m6.87m276.51m194.0023.33--14.761.480.21860.21865.64-4.621.614.2723.35965,118.6013.31--16.33--69.65--8.24--0.91985.454.13--12.37--442.21------
Value Line, Inc.36.63m20.04m455.36m122.0022.734.8521.2812.432.132.133.899.970.2705--26.79300,229.5014.8016.4017.8720.7084.8586.8754.7249.97----0.0045.52-5.560.66955.249.63-8.798.06
Gannett Co Inc2.60bn-96.48m692.24m12.80k--2.7711.700.2665-0.6902-0.690215.661.691.1962.8310.56202,959.10-4.43-7.31-5.89-9.3937.2739.19-3.72-7.350.74980.78560.8028---9.5711.7864.37--26.78--
Scholastic Corp1.60bn23.80m698.65m4.77k54.310.72886.230.43710.45720.457252.9734.070.85652.127.93335,094.301.281.301.901.8855.9952.431.491.620.644218.040.216991.30-6.71-0.7887-85.98-4.95-9.415.92
Cengage Learning Holdings II Inc1.50bn-80.90m1.26bn4.40k----9.750.8353-1.30-1.3024.051.840.572810.497.45341,522.70-3.08-8.41-4.22-10.8352.8350.59-5.38-17.260.75470.84230.9336--5.560.9882-101.24---4.80--
Data as of Oct 31 2024. Currency figures normalised to Biote Corp's reporting currency: US Dollar USD

Institutional shareholders

48.36%Per cent of shares held by top holders
HolderShares% Held
325 Capital LLCas of 30 Jun 20243.77m11.56%
Roystone Capital Management LPas of 31 Dec 20233.07m9.43%
Bandera Partners LLCas of 30 Jun 20242.44m7.48%
BlackRock Fund Advisorsas of 30 Jun 20241.45m4.44%
The Vanguard Group, Inc.as of 30 Jun 20241.33m4.07%
Wasatch Advisors LPas of 30 Jun 20241.29m3.94%
Boston Partners Global Investors, Inc.as of 30 Jun 2024669.73k2.06%
Dimensional Fund Advisors LPas of 30 Jun 2024636.14k1.95%
Geode Capital Management LLCas of 30 Jun 2024618.21k1.90%
SW Investment Management LLCas of 30 Jun 2024500.00k1.54%
More ▼
Data from 30 Jun 2024 - 12 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.